ALEMBIC PHARMACEUTICALS
Back to Balance Sheet
|
ALEMBIC PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹2,514 Cr | ₹1,520 Cr | ₹1,641 Cr | ₹1,831 Cr | ₹1,533 Cr |
What is the latest Total Current Liabilities ratio of ALEMBIC PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹2,514 Cr |
| Mar2024 | ₹1,520 Cr |
| Mar2023 | ₹1,641 Cr |
| Mar2022 | ₹1,831 Cr |
| Mar2021 | ₹1,533 Cr |
How is Total Current Liabilities of ALEMBIC PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,514 Cr | 65.38 | |
| Mar2024 | ₹1,520 Cr | -7.35 | |
| Mar2023 | ₹1,641 Cr | -10.37 | |
| Mar2022 | ₹1,831 Cr | 19.39 | |
| Mar2021 | ₹1,533 Cr | - | |
Compare Total Current Liabilities of peers of ALEMBIC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC PHARMACEUTICALS | ₹14,991.7 Cr | -1% | -11% | -27.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC PHARMACEUTICALS | -1% |
-11% |
-27.4% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses